Riccardo Raneri – Pagina 28

Dicembre 15, 2015 Riccardo Raneri

FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines

16712/2015
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines

Leggi

Dicembre 15, 2015 Riccardo Raneri

FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

16/12/2015
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

Leggi

Aprile 3, 2016 Riccardo Raneri

FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure

05/04/2016
FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure

Leggi

Dicembre 29, 2015 Riccardo Raneri

Standards of Medical Care in Diabetes – 2016

Diabetes Care 2016;39:S4-S5 http://care.diabetesjournals.org/content/39/Supplement_1

Leggi

Gennaio 10, 2016 Riccardo Raneri

FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers.

January 7, 2016 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm480564.htm

Leggi

Aprile 3, 2016 Riccardo Raneri

FDA – Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function

08/04/2016 http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Leggi

Aprile 17, 2016 Riccardo Raneri

EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study

15/04/2016
EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study

Leggi

Gennaio 26, 2016 Riccardo Raneri

AIFA – Gestione del diabete in gravidanza: nuovo standard di qualità del NICE

27/01/2016 http://www.agenziafarmaco.gov.it/it/content/gestione-del-diabete-gravidanza-nuovo-standard-di-qualit%C3%A0-del-nice

Leggi

Aprile 17, 2016 Riccardo Raneri

AIFA – Comunicazione EMA su revisione canaglifozin

15/04/2016
AIFA – Comunicazione EMA su revisione canaglifozin

Leggi

Gennaio 26, 2016 Riccardo Raneri

EMA – Metformin and metformin-containing medicines – Review of metformin-containing medicines started

01/02/2016 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Metoformin_and_ metformin-containing_medicines/human_referral_000397.jsp&mid=WC0b01ac05805c516f

Leggi